Acute Kidney Injury in Cardiac Surgery
Related Experiment Video
Updated: Nov 11, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Christina Massoth1, Alexander Zarbock1, Melanie Meersch1
1Department of Anesthesiology, Intensive Care, and Pain Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, A1, Münster 48149, Germany.
Insights
Cardiac surgery-associated acute kidney injury (AKI) affects 40% of patients, leading to high mortality and costs. Current evidence suggests a multimodal approach including risk stratification, biomarker guidance, dexmedetomidine, and care bundles for prevention.
Area of Science:
- Nephrology
- Cardiology
- Critical Care Medicine
Background:
- Acute kidney injury (AKI) is a frequent and serious complication following cardiac surgery.
- It significantly increases patient morbidity, mortality, and healthcare expenses globally.
- Despite increasing cardiac surgeries, AKI incidence remains high at approximately 40%.
Purpose of the Study:
- To review current evidence and strategies for preventing and managing cardiac surgery-associated AKI.
- To highlight effective approaches based on recent clinical evidence and guidelines.
Main Methods:
- Review of current literature and clinical trial evidence.
- Synthesis of recommendations from expert groups like Kidney Disease: Improving Global Outcomes (KDIGO).
Main Results:
- Effective prevention strategies for cardiac surgery-associated AKI have been challenging to establish.
- Current evidence supports a multimodal approach for managing high-risk patients.
Conclusions:
- A comprehensive strategy involving risk stratification, biomarker-guided management, perioperative dexmedetomidine, and care bundles is recommended.
- Implementation of these measures may help mitigate the impact of AKI after cardiac surgery.
Abstract:
Acute kidney injury (AKI) occurs frequently after cardiac surgery and is associated with high morbidity and mortality. Although the number of cardiac surgical procedures is constantly growing worldwide, incidence of cardiac surgery-associated AKI is still around 40% and has a significant impact on global health care costs. Numerous trials attempted to identify strategies to prevent AKI and attenuate its detrimental consequences. Effective options remained elusive. Current evidence supports a multimodal risk-stratification approach with biomarker-guided management of high-risk patients, perioperative administration of dexmedetomidine, and implementation of a care bundle as recommended by the Kidney Disease: Improving Global Outcomes group.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

